Profil

Avatar

Sanja M. Glišić

Zvanje:
Naučni savetnik
Direktni telefoni:
+38111 2453686
Lokal:
627
Naučna oblast:
1
Veće oblasti:
Zastita zdravlja i životne sredine,
Orcid broj:
0000-0001-5691-1055
Organizaciona jedinica:
180

M faktor

Kategorija Broj Koeficijent Ukupno

Ukupno M faktor:

0
--> -->--> -->--> --> --> -->--> -->--> --> -->-->

NI radovi

# Naziv, Datum, Grupa, Vrsta Godina Autori Status
1 Design of targeting peptides for nanodrugs for treatment of infectious diseases and cancer.
Drug Targeting and Stimuli Sensitive Drug Delivery Systems‐ ELSEVIER. , , 2018
M10 | M13 		2018 Glisic, S., Veljkovic, V.
Odobren
2 Direct-acting antiviral drugs for treatment of hepatitis C virus infection-clinical trials data and chemistry of NS3/4A protease inhibitors.
Frontiers in Clinical Drug Research: Anti-Infectives , , 2020
M10 | M13 		2020 Sencanski, M., Glisic, S.
Odobren
3 The Role of Exercise in Preventing and Treating HIV Infection and Cancer
Physical Activity Effects on the Anthropological Status of Children, Youth and Adults , / , 2016
M10 | M13 		2016 Невена Вељковић, Сања Глишић, Бранислава Гемовић, Вељко Вељковић
Odobren
4 A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin
Bioorganic Medicinal Chemistry , / , 2016
M20 | M21 		2016 Јелица Вучићевић, Srdic-Rajic T, Pieroni M, J. Laurila, Perovic V, Tassini S, Azzali E, Costantino G, Glisic S, Даница Агбаба, Scheinin M, Катарина Николић, Radi M, Невена Вељковић
Odobren
5 Arginase Flavonoid Anti-Leishmanial in Silico Inhibitors Flagged against Anti-Targets
Molecules , / , 2016
M20 | M21 		2016 Сања Глишић, Милан Сенћански, Владимир Перовић, Страхиња Стевановић, Alfonso T. García-Sosa
Odobren
6 Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
J Proteome Res , , 2020
M20 | M21 		2020 Glisic S, Perovic VR, Sencanski M, Paessler S, Veljkovic V.
Odobren
7 Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3
BMC Bioinformatics , / , 2016
M20 | M21 		2016 Сања Глишић, David P. Cavanaugh, Krishnan K. Chittur, Милан Сенћански, Владимир Перовић, Тијана Бојић
Odobren
8 Critical Impact of Different Conserved Endoplasmic Retention Motifs and Dopamine Receptor Interacting Proteins (DRIPs) on Intracellular Localization and Trafficking of the D 2 Dopamine Receptor (D 2-R) Isoforms
Biomolecules , , 2020
M20 | M21 		2020 Kaja Blagotinšek Cokan , Maša Mavri , Catrin Sian Rutland, Sanja Glišić, Milan Senćanski, Milka Vrecl, Valentina Kubale
Odobren
9 Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics.
PLOS one , / , 2014
M20 | M21 		2014 Mandic M, Drinovec L, Сања Глишић, Невена Вељковић, Nohr J, Vrecl M.
Odobren
10 Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic
Frontiers in Microbiology , / , 2016
M20 | M21 		2016 Вељко Вељковић, Paessler Slobodan, Сања Глишић, Јелена Прљић, Владимир Перовић, Невена Вељковић, Matthew Scotch
Odobren
11 Feature-Based Classification of Amino Acid Substitutions outside Conserved Functional Protein Domains
SCIENTIFIC WORLD JOURNAL , / , 2013
M20 | M21 		2013 Бранислава Гемовић, Владимир Перовић, Сања Глишић, Невена Вељковић
Odobren
12 Functional characterization of β2-adrenergic and insulin receptor heteromers
Neuropharmacology , , 2019
M20 | M21 		2019 Maja Susec, Milan Sencanski, Sanja Glisic, Nevena Veljkovic, Christina Pedersen, Luka Drinovec, Jurij Stojan, Jane Nøhr, Milka Vrecl
Odobren
13 Identification of Candidate Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor Which May Improve Vagus Nerve Stimulation in Chronic Tinnitus
Frontiers in neuroscience , , 2017
M20 | M21 		2017 Bojic T, Perovic V, Sencanski M, Glisic S
Odobren
14 Improving attrition rates in Ebola virus drug discovery
Expert opinion on drug discovery , / , 2015
M20 | M21 		2015 Сања Глишић, Paessler Slobodan, Невена Вељковић, Владимир Перовић, Јелена Прљић, Вељко Вељковић
Odobren
15 In silico analysis suggests interaction between Ebola virus and the extracellular matrix
Frontiers in Microbiology , / , 2015
M20 | M21 		2015 Вељко Вељковић, Сања Глишић, Claude P. Muller, Matthew Scotch, Donald R. Branch, Владимир Перовић, Милан Сенћански, Невена Вељковић, Alfonso Colombatti
Odobren
16 In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum
MOLECULES , / , 2018
M20 | M21 		2018 Stevanovic Strahinja, Perdih Andrej, Sencanski Milan, Glisic Sanja, Duarte Margarida, Tomas Ana M., Sena Filipa V., Sousa Filipe M., Pereira Manuela M., Solmajer Tom
Odobren
17 Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism.
VACCINE , / , 2014
M20 | M21 		2014 Вељко Вељковић, Сања Глишић, Невена Вељковић, Bojic T, Dietrich U, Владимир Перовић, Colombatti A.
Odobren
18 Natural Products as Promising Therapeutics for Treatment of Influenza Disease
Current pharmaceutical design , / , 2015
M20 | M21 		2015 Милан Сенћански, Драгиња Радошевић, Владимир Перовић, Бранислава Гемовић, Stanojevic Maja, Невена Вељковић, Сања Глишић
Odobren
19 New in silico and conventional in vitro approaches to advance HIV drug discovery and design
EXPERT OPINION ON DRUG DISCOVERY , / , 2013
M20 | M21 		2013 Maga G., Невена Вељковић, Crespan E., Spadari S., Јелена Прљић, Владимир Перовић, Сања Глишић, Вељко Вељковић
Odobren
20 Novel Phylogenetic Algorithm to Monitor Human Tropism in Egyptian H5N1-HPAIV Reveals Evolution toward Efficient Human-to-Human Transmission
PLOS ONE , / , 2013
M20 | M21 		2013 Владимир Перовић, Muller CP, Niman HL, Невена Вељковић, Ursula Dietrich, Д. Тошић, Сања Глишић, Вељко Вељковић
Odobren
21 Physical activity and natural anti-VIP antibodies: potential role in breast and prostate cancer therapy
PLOS One , / , 2011
M20 | M21 		2011 Veljkovic M, Dopsaj V, Dopsaj M, Branch DR, Невена Вељковић, Sakarellos-Daitsiotis MM, Вељко Вељковић, Сања Глишић, Colombatti A
Odobren
22 Preclinical discovery and development of maraviroc for the treatment of HIV
Expert opinion on drug discovery , / , 2015
M20 | M21 		2015 Невена Вељковић, Vucicevic Jelica, Tassini Sabrina, Сања Глишић, Вељко Вељковић, Radi Marco
Odobren
23 Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China.
PLoS One , / , 2016
M20 | M21 		2016 Вељко Вељковић, Невена Вељковић, Slobodan Paessler, Marco Goeijenbier, Владимир Перовић, Сања Глишић, Claude P. Muller
Odobren
24 Simple and General Criterion for "in silico" Screening of Candidate HIV Drugs
CURRENT PHARMACEUTICAL BIOTECHNOLOGY , / , 2013
M20 | M21 		2013 Невена Вељковић, Сања Глишић, Јелена Прљић, Владимир Перовић, Вељко Вељковић
Odobren
25 Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors.
Front Cell Infect Microbiol , , 2019
M20 | M21 		2019 Radosevic D, Sencanski M, Perovic V, Veljkovic N, Prljic J, Veljkovic V, Mantlo E, Bukreyeva N, Paessler S, Glisic S.
Odobren
26 Aerobic exercise training as a potential source of natural antibodies protective against human immunodeficiency virus-1
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS , / , 2010
M20 | M21a 		2010 Veljkovic M., Dopsaj V., Stringer WW., Sakarellos-Daitsiotis M., Zevgiti S., Вељко Вељковић, Сања Глишић, Dopsaj M.
Odobren
27 An expanded evaluation of protein function prediction methods shows an improvement in accuracy
Genome Biology , / , 2016
M20 | M21a 		2016 Yuxiang Jiang, Tal Ronnen Oron, Wyatt T. Clark, Asma R. Bankapur, Daniel D’Andrea, Rosalba Lepore, Christopher S. Funk, Indika Kahanda, Karin M. Verspoor, Asa Ben-Hur, Da Chen Emily Koo, Duncan Penfold-Brown, Dennis Shasha, Noah Youngs, Richard Bonneau, Alexandra Lin, Mohammad S. E. Sahraeian, Pier Luigi Martelli, Giuseppe Profiti, Rita Casadio, Renzhi Cao, Zhaolong Zhong, Jianlin Cheng, Adrian Altenhoff, Nives Skunca, Christophe Dessimoz, Tunca Dogan, Kai Hakala, Suwisa Kaewphan, Farrokh Mehryary, Tapio Salakoski, Filip Ginter, Hai Fang, Ben Smithers, Matt Oates, Julian Gough, Petri Törönen, Patrik Koskinen, Liisa Holm, Ching-Tai Chen, Wen-Lian Hsu, Kevin Bryson, Domenico Cozzetto, Federico Minneci, David T. Jones, Samuel Chapman, Dukka B. K.C., Ishita K. Khan, Daisuke Kihara, Dan Ofer, Nadav Rappoport, Amos Stern, Elena Cibrian-Uhalte, Paul Denny, Rebecca E. Foulger, Reija Hieta, Duncan Legge, Ruth C. Lovering, Michele Magrane, Anna N. Melidoni, Prudence Mutowo-Meullenet, Klemens Pichler , Aleksandra Shypitsyna, Biao Li, Pooya Zakeri, Sarah El Shal, Léon-Charles Tranchevent, Sayoni Das, Natalie L. Dawson, David Lee, Jonathan G. Lees, Ian Sillitoe, Prajwal Bhat, Tamás Nepusz, Alfonso E. Romero, Rajkumar Sasidharan, Haixuan Yang, Alberto Paccanaro, Jesse Gillis, Adriana E. Sedeño-Cortés, Paul Pavlidis, Shou Feng, Juan M. Cejuela, Tatyana Goldberg, Tobias Hamp, Lothar Richter, Asaf Salamov, Toni Gabaldon, Marina Marcet-Houben, Fran Supek, Qingtian Gong, Wei Ning, Yuanpeng Zhou, Weidong Tian, Marco Falda, Paolo Fontana, Enrico Lavezzo, Stefano Toppo, Carlo Ferrari, Manuel Giollo, Damiano Piovesan, Silvio C.E. Tosatto, Angela del Pozo , José Fernández, Paolo Maietta, Alfonso Valencia, Michael L. Tress, Alfredo Benso, Stefano Di Carlo, Gianfranco Politano, Alessandro Savino, Hafeez Ur Rehman, Matteo Re, Marco Mesiti, Giorgio Valentini, Joachim W. Bargsten, Aalt D. J. van Dijk, Бранислава Гемовић, Сања Глишић, Владимир Перовић, Вељко Вељковић, Невена Вељковић, Danillo C. Almeida-e-Silva , Ricardo Vencio, Malvika Sharan, Jörg Vogel, Lakesh Kansakar, Shanshan Zhang, Slobodan Vucetic, Zheng Wang, Michael J. E. Sternberg, Mark N. Wass, Rachael P. Huntley, Maria J. Martin, Claire O’Donovan, Peter N. Robinson, Yves Moreau, Anna Tramontano, Patricia C. Babbitt, Steven E. Brenner, Michal Linial, Christine A. Orengo, Burkhard Rost, Casey S. Greene, Sean D. Mooney, Iddo Friedberg, Predrag Radivojac
Odobren
28 Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the beta(2)-adrenergic receptor (beta(2)-AR)
SCIENTIFIC REPORTS , / , 2019
M20 | M21a 		2019 Sencanski Milan, Glisic Sanja, Snajder Marko, Veljkovic Nevena, Ulrih Natasa Poklar, Mavri Janez, Vrecl Milka
Odobren
29 Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy
European journal of medicinal chemistry , , 2019
M20 | M21a 		2019 Mirna Jovanović, Daniil Zhukovsky, Ana Podolski-Renić, Ilona Domračeva, Raivis Žalubovskis, Milan Senćanski, Sanja Glišić, Vladimir Sharoyko, Tatiana Tennikova, Dmitry Dar'in, Milica Pešić, Mikhail Krasavin
Odobren
30 Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
Molecules , , 2020
M20 | M22 		2020 Milan Sencanski, Vladimir Perovic, Snezana B. Pajovic, Miroslav Adzic, Slobodan Paessler, Sanja Glisic
Odobren
31 Ibuprofen as a template molecule for drug design against Ebola virus
Frontiers in bioscience (Landmark edition) , , 2018
M20 | M22 		2018 Slobodan Paessler, Cheng Huang, Milan Sencanski, Nevena Veljkovic, Vladimir Perovic, Sanja Glisic, Veljko Veljkovic
Odobren
32 In vitro anti-influenza activity of in silico repurposed candidate drug cycrimine.
Antivir Ther , , 2019
M20 | M22 		2019 Matejin S, Bukreyeva N, Radosevic D, Sencanski M, Mantlo E, Veljkovic V, Glisic S, Paessler S.
Odobren
33 Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets.
Molecules , , 2019
M20 | M22 		2019 Stevanovic S, Sencanski M, Danel M, Menendez C, Belguedj R, Bouraiou A, Nikolic K, Cojean S, Loiseau PM, Glisic S, Baltas M, Garcìa-Sosa AT.
Odobren
34 The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia
Archives of Virology , / , 2016
M20 | M22 		2016 Snezana Jovanovic-Ćupić, Sanja Glišić, Maja Stanojević, Darko Nožić, Nina Petrović, Vesna Mandušić, Milena Krajnović
Odobren
35 The role of long-range intermolecular interactions in discovery of new drugs
Expert Opinion on Drug Discovery , / , 2011
M20 | M22 		2011 Невена Вељковић, Сања Глишић, Владимир Перовић, Вељко Вељковић
Odobren
36 A bioinformatics approach to identify natural autoantibodies from healthy blood donors\' sera reactive with the HCV NS5A-derived peptide by immunoassay
Viral Immunology , / , 2011
M20 | M23 		2011 Vasiljevic N, Невена Вељковић, Kosec T, Ma XZ, Сања Глишић, Јелена Прљић, Vujicic AD, Branch DR, Markovic L
Odobren
37 Assessment of Hepatitis C Virus Protein Sequences with Regard to Interferon/Ribavirin Combination Therapy Response in Patients with HCV Genotype 1b
Protein Journal , , 2012
M20 | M23 		2012 Glisic S, Veljkovic N, Jovanovic Cupic S, Vasiljevic N, Prljic J, Gemovic B, Perovic V, Veljkovic V
Odobren
38 Natural autoantibodies in healthy neonatals recognizing a peptide derived from the second conserved region of HIV-1 gp120
VOJNOSANITETSKI PREGLED , / , 2014
M20 | M23 		2014 Djordjevic-Vujicic Ana, Бранислава Гемовић, Вељко Вељковић, Сања Глишић, Невена Вељковић
Odobren
39 Response Factors to Pegylated Interferon-Alfa/Ribavirin Treatment in Chronic Hepatitis C Patients Genotype 1b.
Archives of biological sciences , / , 2014
M20 | M23 		2014 Снежана Јовановић-Ћупић, С. Глишић, М. Станојевић, N. Vasiljević, Т. Бојић, Ана Божовић, B. Dimitrijević
Odobren
40 Annotation of the functional impact of coding genetic variants.
Biologia Serbica , / , 2017
M30 | M31 		2017 В. Перовић, Б. Гемовић, В. Вељковић, С. Глишић, Н. Вељковић
Odobren
41 Combined in silico approaches for selection of potential Nociceptin receptor ligands
Computational Chemistry for Neurological Targets, COST CM1103 ESR Conference in Belgrade , / , 2015
M30 | M32 		2015 Милан Сенћански, Вељко Вељковић, Драгиња Радошевић, Владимир Перовић, Невена Вељковић, Сања Глишић
Odobren
42 Design of novel NADH dehydrogenase inhibitors as antileishmanial agents
Design of novel NADH dehydrogenase inhibitors as antileishmanial agents , / , 2016
M30 | M32 		2016 С. Стевановић, A. Perdih, С. Глишић, T. Solmajer
Odobren
43 In silico screening of spices with possible anti-HIV ingredients.
Biomedical and Biopharmaceutical Research , / , 2017
M30 | M32 		2017 С. Глишић, Н. Вељковић, В. Перовић, В. Вељковић
Odobren
44 Leishmaniasis - possibilities for drug repurposing
COST Action CM1307 , / , 2017
M30 | M32 		2017 С. Глишић, Н. Вељковић, В. Перовић, В. Вељковић
Odobren
45 Can We Use Standard Tools to Predict Functional Effects of Missense Gene Variations Outside Conserved Domains? TET2 Example
: 2nd INTERNATIONAL CONFERENCE “THEORETICAL APPROACHES TO BIOINFORMATION SYSTEMS” (TABIS.2013) (Druga medjunarodna konferencija “Teorijski pristupi bioinformacionim sistemima” - TABIS.2013) , / , 2014
M30 | M33 		2014 Бранислава Гемовић, Владимир Перовић, Сања Глишић, Невена Вељковић
Odobren
46 Analyses of gene variations in coding regions of molecular markers in myeloid neoplasms: web-application for TET2 gene
ECCB'12 - the European Conference on Computational Biology , / , 2012
M30 | M34 		2012 Н. Вељковић, Б. Гемовић, В. Перовић, С. Глишић, В. Вељковић
Odobren
47 Bioinformatics criterion for selection of candidate dual cr5/cxcr4 inhibitors
GPCR Spring Conference 2014 , / , 2014
M30 | M34 		2014 В. Перовић, Н. Вељковић, Б. Гемовић, Д. Радошевић, С. Глишић
Odobren
48 Bioinformatics approach to protein-protein interactions of WT1 isoforms
IUBMB-FEBS Seville 2012 , / , 2012
M30 | M34 		2012 Бранислава Гемовић, Владимир Перовић, Сања Глишић, Невена Вељковић
Odobren
49 Characterisation of insulin and b2-adrenergic receptor heteromers: experimental and bioinformatics approach
17th European Congress of Endocrinology , / , 2015
M30 | M34 		2015 Maja Mandic, Сања Глишић, Christina Pedersen, Невена Вељковић, Jane Nøhr, Milka Vrecl
Odobren
50 Combined in silico approaches for selection of novel nociceptin receptor small molecule agents
COST Action CM1207 – GLISTEN: GPCR-Ligand Interactions, Structures, and Transmembrane Signalling – A European Research Network , / , 2015
M30 | M34 		2015 Милан Сенћански, Вељко Вељковић, Драгиња Радошевић, Владимир Перовић, Невена Вељковић, Сања Глишић
Odobren
51 Combined in silico approaches for the selection of antileishmanial inhibitors
Chemotherapy towards diseases caused by endoparasites - COST action CM1307 2nd conference WG2 and WG3 Meetings , / , 2015
M30 | M34 		2015 Сања Глишић, Милан Сенћански, Невена Вељковић, Драгиња Радошевић, Владимир Перовић, Вељко Вељковић
Odobren
52 COMBINED IN SILICO APPROACHES FOR THE SELECTION OF DUAL CCR5/CXCR4 INHIBITORS
GLISTEN Budapest 2014 Conference , / , 2014
M30 | M34 		2014 Milan Sencanski, Невена Вељковић, Сања Глишић, Владимир Перовић, Драгиња Радошевић, Marco Radi
Odobren
53 Identification by the Informational Spectrum Method of Giardia protein g14-3-3 domain which is involved in formation of g14-3-3/gCDC7/gDBF4 complex
1st COST CM1307 Conference /CaPF joint meeting , / , 2014
M30 | M34 		2014 Сања Глишић, Marco Lalle, Вељко Вељковић
Odobren
54 Identification of estrogen responsive element in the human immunodeficiency virus (type 1) long terminal repeat
IUBMB-FEBS Seville 2012 , / , 2012
M30 | M34 		2012 Radosevic D., Невена Вељковић, Сања Глишић
Odobren
55 Identification of nanobody derived peptides stabilizing functional conformational state of the beta2 adrenergic receptor (β2AR)
GLISTEN Symposium , / , 2017
M30 | M34 		2017 С. Глишић, М. Сенћански, Н. Вељковић, M. Vrecl
Odobren
56 Importance of the insulin receptor intracellular domain for the heterodimerization with the beta2 adrenergic receptor
COST CM1207 GLISTEN meeting 1 - 2 April 2015 Allschwil, Switzerland , / , 2015
M30 | M34 		2015 Сања Глишић, Maja Mandic, Невена Вељковић, Jane Nohr, Milka Vrecl
Odobren
57 In silico screening for GSK-3ß inhibitors as potential radioprotectors
International conference on radiation applications (RAP 2019), 16–19.09.2019. Belgrade, Serbia, Book of Abstracts, p. 133 , , 2019
M30 | M34 		2019 Gavrilović Lj, Senćanski M, Radošević D, Glišić S.
Odobren
58 In silico screening of database of natural products for the selection of dual HIV CCR5/CXCR4 candidate inhibitors
Challenging organic synthesis inspired by nature - From natural products chemistry to drug discovery - 1st Meeting of COST Action CM1407 Rome, 5-6 October 2015 , / , 2015
M30 | M34 		2015 Сања Глишић, Невена Вељковић, Владимир Перовић, Вељко Вељковић
Odobren
59 In silico screening of drug space, nutraceuticals and natural compounds for candidate antimalarians
1st COST CM1307 Conference /CaPF joint meeting , / , 2014
M30 | M34 		2014 Вељко Вељковић, Bruno Botta, Maurizio Botta, Mattia Mori, Невена Вељковић, Сања Глишић
Odobren
60 M1 targeted vagus nerve stimulation-new therapeutical approach for chronic tinnitus?
*10th International Tinnitus Research Initiative Conference and 1st EU COST action (TINNET) Conference. Tinnitus: subtypes, mechanisms and interventions, 16-18th March 2016, Nottingham, UK. , / , 2016
M30 | M34 		2016 Т. Бојић, М. Сенћански, В. Перовић, С. Глишић
Odobren
61 Predicting protein function from sequence and co-expression:preliminary results for breast cancer molecular markers.
FEBS EMBO 2014 Conference , / , 2014
M30 | M34 		2014 Бранислава Гемовић, Владимир Перовић, Сања Глишић, Невена Вељковић
Odobren
62 Protein-protein interaction prediction method based on principle component analysis of amino acid physicochemical properties
Belgrade Bioinformatics Conference, BELBI 2016, Belgrade, Serbia, June 20th-24th -Book of abstracts , / , 2016
M30 | M34 		2016 Невена Вељковић, Сања Глишић, Владимир Перовић, Невен Шумоња
Odobren
63 Rapid and Efficient Method for Phylogenetic Analyses Based on Digital Signal Processing Techniques
Biocuration 2016, The Ninth International Biocuration Conference, Geneva, Switzerland, from April 10-14, 2016 , / , 2016
M30 | M34 		2016 Владимир Перовић, Вељко Вељковић, Сања Глишић, Невена Вељковић
Odobren
64 Rational design and computational profiling of I1 agonists/antagonists for GPCRs
GLISTEN 2016 Autumn conference, September 26th-28th, 2016, Prague,Czech Republic , / , 2016
M30 | M34 		2016 Jelica Vucicevic, Татјана Срдић-Рајић, Катарина Николић, Сања Глишић, Владимир Перовић, Невен Шумоња, Marco Pieroni, Jonne M.M. Laurila, Sabrina Tassini, Elisa Azzali, Gabriela Costantino, Danica Agbaba, Mika Scheinin, Henri Xhaard, Marco Radi, Н. Вељковић
Odobren
65 Selection of nanobody derived peptides that stabilize functional conformational state of the beta2 adrenergic receptor
GLISTEN Symposium , / , 2017
M30 | M34 		2017 С. Глишић, М. Сенћански, Н. Вељковић, M. Vrecl
Odobren
66 Simple theoretical criterion for selection of candidate HIV drugs
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) , / , 2011
M30 | M34 		2011 Н. Вељковић, С. Глишић, В. Перовић, В. Вељковић
Odobren
67 Treadmill running changes gene expression of catecholamine biosynthetic enzymes only in the left adrenal medulla of adult rats
International conference on radiation applications (RAP 2019), 16–19.09.2019. Belgrade, Serbia, Book of Abstracts, p. 131. , , 2019
M30 | M34 		2019 Gavrilović Lj, Dronjak S, Glišić S, Stojiljković V.
Odobren
68 Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of leishmaniasis
COST Action CM1307 , / , 2017
M30 | M34 		2017 В. Вељковић, N. Fasel, R. Eren, D. Kopelyanskiy, S. Paessler, С. Глишић
Odobren
69 Uloga genetičkih markera u sportu i rekreativnoj fizičkoj aktivnosti
Fizička kultura , / , 2016
M50 | M51 		2016 Сања Глишић, Драгиња Радошевић, Владимир Перовић, Невен Шумоња, Бранислава Гемовић, Невена Вељковић, Миливој Допсај
Odobren
70 PCT/EP2015/059424 PEPTIDE AGONISTS OF TOLL-LIKE RECEPTOR 5 AND METHODS OF USE
PCT/EP2015/059424 PEPTIDE AGONISTS OF TOLL-LIKE RECEPTOR 5 AND METHODS OF USE , / , 2015
M90 | M91 		2015 Alfonso Colombatti, Roberto Doliana, Вељко Вељковић, Невена Вељковић, Сања Глишић, Владимир Перовић
Odobren
71 In silico screening of Zinc Database of Natural Products for 5HT6 Receptor Antagonists to Cure Alzheimer Disease
Molecules , , 2022
M20 | M22 		2022 Tijana Bojić, Milan Senćanski, Vladimir Perović, Sanja Glišić
Odobren
72 M23
Front Biosci (Landmark Ed) . , , 2022
M20 | M23 		2022 Veljković V, Glišić S, Perović V, Veljković M, Paessler S
Odobren
73 Inhibition of SARS-CoV-2 Mpro with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination
Frontiers in Bioscience-Landmark , , 2023
M20 | M23 		2023 Ivana Đukić, Nevena Kaličanin, Milan Sencanski, Snezana B. Pajovic, Jelena Milicevic, Jelena Prljic, Slobodan Paessler, Radivoje Prodanović, Sanja Glisic
Odobren
74 In Silico and In Vitro Inhibition of SARS-CoV-2 PLpro with Gramicidin D
International Journal of Molecular Sciences , , 2023
M20 | M21 		2023 Sara Protić, Nevena Kaličanin, Milan Sencanski, Olivera Prodanović, Jelena Milicevic, Vladimir Perovic, Slobodan Paessler, Radivoje Prodanović, Sanja Glisic
Odobren
75 Patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis
Cellular & Molecular Biology Letters , , 2023
M20 | M21 		2023 Maša Mavri, Sanja Glišić, Milan Senćanski, Milka Vrecl, Mette M. Rosenkilde, Katja Spiess, Valentina Kubale
Odobren
76 In Silico Investigation of Selected Pesticides and Their Determination in Agricultural Products Using QuEChERS Methodology and HPLC-DAD
International Journal of Molecular Sciences , , 2023
M20 | M21 		2023 Stefan Petrović, Biljana Arsić, Ivana Zlatanović, Jelena Milićević, Sanja Glišić, Milan Mitić, Rada Đurović-Pejčev, Gordana Stojanović
Odobren
77 In silico and stability analyses of selected pesticides in use in Serbia
29th Annual Meeting of the Slovenian Chemical Society , Portorož, Slovenia , 2023
M30 | M34 		2023 Jelena Milićević, Biljana Arsić, Stefan Petrović, Snežana Tošić, Ivana Dimitrijević, Gordana Stojanović, Sanja Glišić
Odobren
78 Repurposing of approved drugs as candidates for the treatment of kala-azar: a computational study on Rab5a and PTR1 from Leishmania donovani as targets
German Conference on Bioinformatics, GCB 2023 , Hamburg, Germany , 2023
M30 | M34 		2023 Biljana Arsić, Jovana Janjić, Jelena Milićević, Sanja Glišić
Odobren
79 In silico screening of Solanum lycopersicum carotenoids from Carotenoids Database for candidates PPARα agonists
2nd International Conference on Chemo and Bioinformatics ICCBIKG_2023 , , 2023
M30 | M33 		2023 Tamara Drljača, Kristina Stevanović, Draginja Radošević, Jelena Milićević, Nevena Veljković, Sanja Glišić
Odobren
80 Combined in silico approach to identify new terpenoid PPARα agonists
2nd International Conference on Chemo and Bioinformatics ICCBIKG 2023 , Kragujevac, Serbia , 2023
M30 | M33 		2023 Kristina Stevanović, Draginja Radošević, Vladimir Perović, Sanja Glišić
Odobren
81 Coumarins as promising PPARα agonists. Novel in silico insights
2nd International Conference on Chemo and Bioinformatics ICCBIKG 2023 , Kragujevac, Serbia , 2023
M30 | M33 		2023 Draginja Radošević, Kristina Stevanović, Vladimir Perović, Sanja Glišić
Odobren
82 Drugs repurposing for candidate NLRP3 inhibitors by combined in silico method
1st ML4NGP Meeting on Machine Learning and Non-Globular Proteins , Bratislava, Slovakia , 2023
M30 | M34 		2023 Kristina Stevanović, Draginja Radošević, Vladimir Perović, Sanja Glišić
Odobren
83 Combined in silico approach in screening of flavonoids database for potential NLRP3 inhibitors
10th IAPC Meeting, Tenth World Conference on Physico-Chemical Methods in Drug Discovery & Sixth World Conference on ADMET and DMPK , Beograd , 2023
M30 | M34 		2023 Kristina Stevanović, Draginja Radošević, Vladimir Perović, Sanja Glišić
Odobren
84 Identification of the new candidate NLRP3 inhibitor using combined computational approach
9th Conference of Young Chemists of Serbia , Novi Sad, Serbia , 2023
M60 | M64 		2023 Kristina Stevanović, Milan Senćanski, Vladimir Perović, Sanja Glišić
Odobren
85 Stability and computational analyses of selected pesticides in use in the Republic of Serbia
Journal of the Serbian Chemical Society , , 2023
M20 | M23 		2023 Biljana Arsic, Stefan Petrovic, Jelena Mrmosanin, Ivana Dimitrijevic, Snezana Tosic, Gordana Stojanovic, Sanja Glisic, Jelena Milicevic
Odobren
86 Computational Modeling and Characterization of Peptides Derived from Nanobody Complementary-Determining Region 2 (CDR2) Targeting Active-State Conformation of the β2-Adrenergic Receptor (β2AR)
Biomolecules , , 2024
M20 | M21 		2024 Milan Sencanski, Sanja Glisic, Valentina Kubale, Marko Cotman, Janez Mavri, Milka Vrecl
Odobren
87 Identification of the NLRP3 structural domain crucial for its activation and new bioinformatics criterion for assessment of mutations as a risk factor for inflammatory diseases
2nd ML4NGP meeting on "Machine Learning and Non-globular proteins" , Thessaloniki, Greece , 2024
M30 | M34 		2024 Kristina Stevanović, Vladimir Perović, Sanja Glišić
Odobren
88 Exploring the Antiviral Potential of Natural Compounds against Influenza: A Combined Computational and Experimental Approach
International Journal of Molecular Sciences , , 2024
M20 | M21 		2024 Vladimir Perovic, Kristina Stevanovic, Natalya Bukreyeva, Slobodan Paessler, Junki Maruyama, Sergi López-Serrano, Ayub Darji, Milan Sencanski, Draginja Radosevic, Simone Berardozzi, Bruno Botta, Mattia Mori, Sanja Glisic
Odobren
89 Inhibition of butyrylcholinesterase activity by abamectin and boscalid: computational and in vitro studies
60th Meeting of the Serbian Chemical Society , , 2024
M60 | M64 		2024 Biljana B. Arsić, Milka Vrecl, Tomaž Trobec, Kristina Sepčić, Robert Frangež, Sanja M. Glišić, Jelena S. Milićević
Odobren
90 In Silico Exploration of CD200 as a Therapeutic Target for COVID-19
Microorganisms , , 2024
M20 | M22 		2024 Vladimir Perovic, Sanja Glisic, Milena Veljkovic, Slobodan Paessler, Veljko Veljkovic
Odobren
91 SARS-CoV-2 PLpro Inhibition: Evaluating in Silico Repurposed Fidaxomicin's Antiviral Activity Through In Vitro Assessment
ChemistryOpen , , 2024
M20 | M22 		2024 Sara Protić, Milica Crnoglavac Popović, Nevena Kaličanin, Olivera Prodanović, Milan Senćanski, Jelena Milićević, Kristina Stevanović, Vladimir Perović, Slobodan Paessler, Radivoje Prodanović, Sanja Glišić
Odobren

Citati

Broj citata Referenca Status
628.0 Link | Dokument
Odobren